IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates
Disc Medicine, Inc. (IRON)
Company Research
Source: GlobeNewswire
NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP is investigating Disc Medicine, Inc. (NASDAQ: IRON) regarding whether the company adequately communicated risks regarding its bitopertin program before the FDA’s issuance of a Complete Response Letter on February 13, 2026, which caused a 21.9% decline in share price. Investors who suffered losses on IRON stock may click here for additional information about this investigation. The Complete Response Letter for Disc’s bitopertin indicated that the FDA required additional data before it could approve the drug for erythropoietic protoporphyria (EPP). The nature of the additional data requirements has not been fully detailed publicly, but the issuance of a CRL typically signals deficiencies in clinical efficacy data, safety concerns, or manufacturing issues that the agency considers unresolved. Each category carries different implications for the timeline and cost of a potential resubmission. In this instance, the FDA i
Show less
Read more
Impact Snapshot
Event Time:
IRON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRON alerts
High impacting Disc Medicine, Inc. news events
Weekly update
A roundup of the hottest topics
IRON
News
- IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law FirmBusiness Wire
- IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc MedicinePR Newswire
- Evaluating Disc Medicine (IRON) After Recent Share Moves And Conflicting Valuation Signals [Yahoo! Finance]Yahoo! Finance
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRONGlobeNewswire
- Disc Medicine (IRON) had its price target raised by Wells Fargo & Company from $78.00 to $79.00. They now have an "overweight" rating on the stock.MarketBeat
IRON
Earnings
- 2/26/26 - Miss
IRON
Sec Filings
- 3/4/26 - Form 4
- 3/2/26 - Form 144
- 2/27/26 - Form 4
- IRON's page on the SEC website